At Zoetis, the challenge was a highly complex portfolio spanning seven therapeutic areas, which created fragmentation in how the market understood the brand and diluted overall corporate equity. The mandate was to unify the portfolio under a cohesive brand system that could scale consistently across global markets and audiences, while reinforcing category leadership and strengthening brand preference.We approached the transformation in three parts: narrative, visual identity, and activation.
‍
First, we developed a narrative architecture anchored in science and innovation, which represented the company’s highest-leverage differentiator. Zoetis’ R&D leadership was a key source of competitive advantage, and the goal was to elevate it into a unifying theme that was strong enough to anchor the brand, yet flexible enough to resonate across both B2B and broader stakeholder audiences.

Second, we evolved the visual identity away from a fragmented, multi-color palette to a more monochromatic design system that reduced noise, strengthened recognition, and created a more premium, cohesive expression.

Third, we activated the brand across channels by rebuilding the website, refreshing the social ecosystem, launching integrated campaigns, and strengthening SEO/SEM to ensure consistent expression of the new positioning in market.

Ultimately, the work created a scalable brand system that unified the portfolio and reinforced Zoetis’ leadership position in animal health innovation